Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

307 results about "Carnitine" patented technology

Carnitine (β-hydroxy-γ-N-trimethylaminobutyric acid, 3-hydroxy-4-N,N,N-trimethylaminobutyrate) is a quaternary ammonium compound involved in metabolism in most mammals, plants, and some bacteria. Carnitine may exist in two isomers, labeled D-carnitine and L-carnitine, which are both biologically active. At room temperature, pure carnitine is a white powder, and a water-soluble zwitterion with low toxicity. Carnitine only exists in animals as the L-enantiomer, and D-carnitine is toxic because it inhibits the activity of L-carnitine. Carnitine, derived from an amino acid, is found in nearly all organisms and animal tissue. Carnitine is the generic expression for a number of compounds that include L-carnitine, acetyl-L-carnitine, and propionyl-L-carnitine. It is most accumulated in cardiac and skeletal muscles as it accounts for 0.1% of its dry matter. It was first derived from meat extracts in 1905, therefore the name carnitine is derived from Latin "carnus" or flesh. The body synthesizes enough carnitine from lysine side chains to keep up with the needs of energy production in the body as carnitine acts as a transporter of long-chain fatty acids into the mitochondria to be oxidized and produce energy. Some individuals with genetic or medical disorders (such as preterm infants) cannot make enough, so this makes carnitine a conditionally essential nutrient for them.

Oral instant film and preparation method thereof

The invention discloses an oral instant film suitable for pet nutrition intervention and a preparation method of the oral instant film, and belongs to the technical field of pet oral preparations. The instant film adopts a sandwich type multi-layer structural design, sequentially comprises a first food calling layer, a core layer and a second food calling layer, can be selectively provided with a functional layer and an interface middle layer, and constructs a staggered hot-pressing laminated structure, so that the structural stability and the function delivery efficiency of a film body are remarkably improved. The core layer contains multiple composite active ingredients such as L-carnitine, coenzyme Q10, beta-glucan, glucosamine sulfate and the like, chitosan-inulin-polyglutamic acid or starch is adopted for embedding to form a first microcapsule and a second microcapsule, and intelligent delivery of temperature / pH response and gastrointestinal controlled release is achieved. The food calling layer is composed of chicken powder, fish oil powder, fructo-oligosaccharide and the like, and the feeding compliance of pets is improved.
Owner:HUNAN SHANGCHENG BIOTECHNOLOGY CO LTD

Diglyceride oil powder for body weight management and preparation method thereof

The invention relates to the technical field of weight management, in particular to diglyceride oil powder for weight management and a preparation method of the diglyceride oil powder. The invention discloses diglyceride oil powder for weight management. The diglyceride oil powder comprises the following substances in parts by weight: 18-30 parts of flaxseed diglyceride; 10 to 20 parts of a konjak extract; 3 to 8 parts of L-carnitine; 3-8 parts of a white kidney bean extract; 2-5 parts of a green coffee extract; the flaxseed diglyceride is flaxseed diglyceride in which the sn-1, 3 structure proportion is greater than or equal to 85%. The multi-target body weight regulation network is constructed by taking flaxseed diglyceride as a core and combining the konjak extract, the L-carnitine, the white kidney bean extract and the green coffee extract. And a synergistic effect of'fat-carbon water double blocking + energy consumption 'is formed. The composition breaks through the action limitation of a single component by regulating and controlling full links of intake, absorption and metabolism.
Owner:TIMES FORMULAS FOR SPECIAL MEDICAL PURPOSES (SHENZHEN) CO LTD

Biomarkers and use thereof for diagnosis, prevention, and treatment of muscle atrophy

There is provided a method for diagnosing a subject with early onset muscle atrophy, said method comprising: obtaining a biosample from the subject; and assaying the biosample for one or more biomarkers, said one more biomarkers are taurine, proline, citrulline, trigonelline, thymidine, ornithine, glutamate, L-pyroglutamic acid, creatinine, adenine, nicotinamide, 2-methylhippuric acid, maltol, L-arginine, hypotaurine, L-glutamine, homogentisic acid, methylhistidine, oxoglutaric acid, xanthine, L-carnitine, succinate, or a combination thereof; and identifying the subject with early onset muscle atrophy on the basis of a deviation in the one or more of said one more biomarkers.
Owner:MYOMAR MOLECULAR INC

Hypoglycemic composition containing supramolecular group composite peptide and application of hypoglycemic composition in functional food and medicine

The invention discloses a hypoglycemic composition containing supramolecular group composite peptide. The hypoglycemic composition comprises collagen peptide, soybean peptide, bitter gourd peptide, bamboo leaf flavone, L-carnitine and the like. The composition prepared by selecting raw material components of specific types and dosages has the effects of remarkably reducing the glucose level and increasing the insulin level, and part of the composition can also cooperate with metformin to achieve the effects of enhancing the effect of reducing blood sugar and improving or preventing type 2 diabetes mellitus. Therefore, the method can be used for developing functional foods and medicines and has a considerable market prospect.
Owner:HANGZHOU HUANTE BIOLOGICAL TECH CO LTD

Feed premix for improving chicken quality

The invention provides a feed premix for improving chicken quality. The fresh-keeping agent is prepared from the following components in percentage by weight: 5%-15% of a flavor enhancing component, 10%-25% of a tenderness improving component, 3%-10% of an antioxidant fresh-keeping component, 2%-3% of a function enhancing component and the balance of a carrier and a diluent, the function strengthening component is prepared from beta-alanine embedded citronella essential oil and konjac glucomannan zymolyte; the flavor enhancing component comprises a rosemary extract, a yeast culture and curcumin in a mass ratio of (2-4): (1-3): 1; the tenderness improving component comprises conjugated linoleic acid, L-carnitine modified by glutamine transaminase and betaine in a mass ratio of (3-5): (2-4): 1; the antioxidant fresh-keeping component is vitamin E and tea polyphenol in a mass ratio of (1-2): 1. Through multi-component synergism and functional targeting optimization, a three-dimensional quality improvement system with enhanced flavor, improved tenderness, oxidation resistance and fresh keeping is constructed, so that the chicken quality is comprehensively upgraded.
Owner:BAIHE (SHANGHAI) BIOTECHNOLOGY CO LTD

Application of N-acetylglutamic acid in preparation of anti-myocardial fibrosis drugs

The invention relates to the field of biological medicines, and discloses application of N-acetylglutamic acid in preparation of anti-myocardial fibrosis medicines. According to the application disclosed by the invention, the N-acetylglutamic acid and the carglutamic acid are found to have the effects of obviously improving the systolic function of the heart, reducing the energy metabolism deposition of the fibroblasts and reducing the collagen deposition so as to inhibit excessive fibrosis of the myocardial fibroblasts after myocardial infarction for the first time. The discovery provides a'switch 'for fibroblast repair of myocardial infarction and excessive fibrosis, and has important value for avoiding the excessive fibrosis of the heart after myocardial infarction.
Owner:ZHEJIANG UNIV

Technology development and application of new special medical food based on new food raw material framework

The invention relates to technical development and application of new special medical food on the basis of a new food raw material framework, and belongs to the technical field of special medical purpose formula food (FSMP). According to the series of foods, new food raw materials (euglena, haematococcus pluvialis and ampelopsis grossedentata leaves) are taken as cores, medicinal and edible components (lotus leaves, haws and mulberry leaves) and marine active substances (fucoidan polysaccharides and chitin) are combined, functional factors are extracted through a prehydrolysis SBE technology and a biological enzymolysis technology, and the bioavailability is improved by adopting a nano-carrier technology. The product comprises a total nutrient base material (20-30% of protein and 15-25% of dietary fiber), functional components (10-15% of a new food raw material extract and 8-12% of a traditional Chinese medicine extract) and a metabolism regulator (conjugated linoleic acid and L-carnitine). Clinical tests show that after an obese patient takes 400 kcal of the replacement meal every day, the weight of the obese patient is reduced by 10.2 kg on average (4.8 kg of a control group) 12 weeks later, and the body fat rate is reduced by 16.3%. The product supports line iteration (such as powder, tablets and liquid food) through modular formula design, and fills the application blank of new food raw materials in special medical food.
Owner:SHANXI TONGWEN VOCATIONAL & TECHNICAL COLLEGE

A meal replacement powder for weight loss in obese patients and a method for preparing the same

The application belongs to the technical field of functional food, and particularly discloses a meal replacement powder for weight loss of obese patients and a preparation method thereof. The meal replacement powder comprises whey protein powder, composite dietary fiber (containing at least two kinds of konjac powder and the like), functional carbohydrate, functional fat (containing medium-chain fatty acid and the like), and composite vitamins, minerals, functional additives (L-carnitine and the like), and stability additives. The preparation comprises raw material pretreatment, small material premixing, large material mixing, microencapsulation of fat-soluble components, total mixing, sterilization and packaging, and the key lies in that the fat-soluble components are wrapped by wall materials and spray dried into microcapsules. The meal replacement powder can balance nutrition, strengthen satiety, promote fat metabolism, avoid muscle loss and electrolyte imbalance, has a shelf life of 12 months at room temperature, has good palatability, has good weight loss effect (average weight loss of 5.8 kg in 2 months), has no adverse reactions, and is suitable for long-term weight loss diet management of obese patients.
Owner:石霞

Uses of engineered yeast strains and lipid compositions thereof

PCT designated stageWO2025212524A1Organic active ingredientsDigestive systemMonoglycerideCellular Aging
Provided herein are methods and materials for using organisms (e.g., engineered yeast strain-derived) to generate lipid compositions which can modulate cellular aging, extend lifespan, and / or modulate gut homeostasis in a subject. The lipid compositions contain at least twelve of the lipids selected from a phosphatidylethanolamine (PE); a lysophosphatidylethanolamine (LPE); a diacylglycerol (DG); a monoglyceride (MG); an acyl carnitine (AcCa); a phosphatidic acid (PA); a phosphatidylglycerol (PG); a lysophosphatidylcholine (LPC); a triacylglycerol (TG); a cholesterol ester (ChE); a wax ester (WE); a phosphatidylserine (PS); a phosphatidylcholine (PC); a phosphatidylinositol (PI); a ceramide (Cer); and a lysophosphatidylserine (LPS).
Owner:RGT UNIV OF CALIFORNIA

Anti-aging capsule compounded by PQQ and mitochondrial nutrients

The invention relates to an anti-aging capsule compounded by PQQ and mitochondrial nutrients, and discloses an anti-aging capsule which is prepared by synergistically compounding a plurality of mitochondrial nutrients according to a scientific proportion and supplementing high-purity raw materials and slow-release dosage forms to realize energy metabolism activation and anti-oxidation synergistic intervention. Therefore, the anti-aging capsule systematically delays aging through multi-target regulation and control of mitochondrial functions. The capsule is characterized by comprising the following components in parts by weight: 1-20 mg of pyrroloquinoline quinone disodium salt (PQQ), 20-100 mg of coenzyme Q10, 50-200 mg of L-carnitine tartrate, 10-100 mg of alpha-lipoic acid, 50-300 mg of nicotinamide mononucleotide (NMN) or nicotinamide nucleoside (NR), and 10-50 [mu] g of selenoprotein or organic selenium yeast, and a capsule carrier comprises 100 mg of gelatin or a plant-derived capsule shell, 180 mg of microcrystalline cellulose, 5 mg of magnesium stearate and 5 mg of silicon dioxide.
Owner:JIANGSU SHAREJOY HEALTH TECH CO LTD

Astragaloside synergistic composition as well as preparation method and application thereof

The invention discloses an astragaloside synergistic type composition as well as a preparation method and application of the astragaloside synergistic type composition. Comprising the following components: 8 to 16 parts of astragaloside, 20 to 40 parts of a honeysuckle flower extract, 10 to 20 parts of L-carnitine, 0.1 to 0.5 part of selenium yeast, 3 to 8 parts of diammonium glycyrrhizinate, 5 to 15 parts of taurine, 8 to 20 parts of a fructus forsythiae extract, 2 to 7 parts of vitamin E, 12 to 32 parts of hydroxypropyl-beta-cyclodextrin, 2 to 10.5 parts of maltodextrin, 1 to 7 parts of Arabic gum, 10 to 20 parts of lactose, 1 to 3 parts of zinc gluconate and 2 to 5 parts of magnesium stearate. 1-3 parts of vitamin C, 1-5 parts of xanthan gum and 1-3 parts of lecithin. The composition has a wide application prospect in preparation of veterinary drugs or veterinary food additives.
Owner:JIANGXI CHENGBIXIN BIOTECHNOLOGY CO LTD

Dried blood spot liquid chromatography-mass spectrometry detection method adaptive to 7 types of metabolites

The invention belongs to the technical field of biological medicine, and discloses a dry blood spot liquid chromatography-mass spectrometry detection method adaptive to 7 metabolites. According to the method, a pH / polarity double-trigger microcapsule solvent carrier system is adopted, high-polarity extraction solvents, medium-polarity extraction solvents and low-polarity extraction solvents are packaged in the pH / polarity double-trigger microcapsule solvent carrier system in a layered mode, the solvents are released in sequence according to local pH and polarity changes in the extraction process, and amino acid, acyl carnitine, organic acid, bile acid, steroid, fatty acid and glycometabolism intermediate products are efficiently extracted respectively. The method disclosed by the invention breaks through the inherent limitation of a traditional static solvent system, solves the problem of unbalanced recovery rate caused by insufficient solvent suitability in dry blood spot extraction of seven metabolites with great polarity span, and remarkably improves the accuracy, reproducibility and coverage range of a DBS-LC-MS / MS platform in synchronous detection of multi-component metabolites; and reliable technical support is provided for newborn inherited metabolic disease screening, endocrine disease diagnosis and drug metabolism research.
Owner:SHANGHAI BIOTREE

Functional Alternative coffee composition

PendingKR1020260140163ABiotechnologyAglycone
The present invention relates to a functional coffee substitute composition. The coffee substitute food composition comprising a fermented dandelion root extract, a fermented Acanthopanax seed extract, and a fermented soybean extract of the present invention possesses sensory characteristics similar to coffee, and through fermentation, the content of major plant functional components such as isoflavone aglycone, total polyphenols, flavonoids, and saponins increases, L-carnitine is newly synthesized, and since it is a novel coffee substitute food material having antioxidant effects and anti-diabetic activity, it can be utilized as a caffeine-reducing beverage, a beverage that promotes body fat metabolism, an antioxidant-enhanced beverage, and a health functional food.
Owner:SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION

Feline triple vaccine immunoadjuvant containing two feline interleukins and a metabolic regulator molecule, compositions and uses

The present application relates to the technical field of biological medicine, and in particular to a cat triple vaccine immune adjuvant containing two kinds of cat interleukins and metabolic regulatory molecules, a composition and application. The composition comprises cat interleukin 15, cat interleukin 23 and a metabolic regulatory molecule, the metabolic regulatory molecule comprises beta-nicotinamide mononucleotide, beta-nicotinamide adenine dinucleotide disodium salt, N-acetyl cysteine and L-carnitine, and can be used for preparing a cat triple vaccine or an auxiliary preparation of the cat triple vaccine. The composition can effectively improve the protection of the vaccine, prolong the protection time of the vaccine and reduce adverse reactions; the vaccine can more durably and at a higher level reduce or control the reproductive infection of viruses, significantly improve the specific humoral immune level and memory response ability of animals, and better resist the invasion and spread of FPV, FCV and FHV-1.
Owner:SICHUAN SANYOUKANG BIOTECHNOLOGY CO LTD

Complete-cycle nutrition-enhanced goat hybridization breeding method

The invention relates to the technical field of livestock and poultry breeding, in particular to a goat hybridization breeding method capable of achieving complete-cycle nutrition enhancement. The core of the method is that systematic nutrition intervention runs through the whole breeding process. Before hybridization, performing differential nutrition pretreatment on the parents for 60 days: feeding the female parents with a breeding nutrition enhancer added with components such as D-chiro-inositol and N-acetylcysteine, and supplementing sperm motility enhancer containing acetylated L-carnitine and ergothioneine to the male parents. In the gamete treatment stage, the oocytes are subjected to in-vitro maturation culture in a special culture solution containing components such as D-chiro-inositol and a growth differentiation factor 9; after the sperms are subjected to gradient centrifugal screening, completing in-vitro fertilization in an optimized fertilization culture solution; after the embryos develop into blastocysts in the sequential culture system, carrying out laparoscopic transplantation, and carrying out staged precise nutrition culture on the pregnant ewes. According to the method, through multi-level nutrition enhancement, the reproductive capacity of the goats and the growth performance of offspring are effectively improved.
Owner:XINJIANG ACAD OF ANIMAL SCI

Equipment and method for treating high-salinity wastewater generated in production of L-carnitine

The invention discloses L-carnitine production high-salinity wastewater treatment equipment which is characterized in that a feeding pump is connected with a first-effect evaporator, an external steam control valve is connected with the first-effect evaporator, a first pressure gauge is mounted at the input end or the output end of the external steam control valve, and the output end of the first-effect evaporator is connected with the input end of a second-effect evaporator; the system further comprises a wiped-film evaporator, a condensing unit and a vacuumizing unit, the wiped-film evaporator is provided with a plurality of input ends and a plurality of output ends, and the input ends of the wiped-film evaporator are connected with the output end of the second-effect evaporator; the input end of the condenser is connected with the first output end of the wiped-film evaporator, and the cooling liquid input control valve and the cooling liquid output control valve are respectively connected with the condenser; the output end of the condenser is connected with one end of the adjusting valve through a third pipeline, the other end of the adjusting valve is connected with the vacuum pump, and the second pressure gauge is connected with the third pipeline. According to the invention, energy consumption and cost can be reduced.
Owner:陈文阳

Pentadecanoylcarnitine for treatment of conditions related to the quality of aging and longevity

Administration of pentadecanoylcarnitine or pentadecanoic acid is provided for prevention, management or treatment of aggression, allergies, allergic rhinitis, Alzheimer's disease, anxiety and anxiety disorders, amyotrophic lateral sclerosis, arthritis, asthma, atherosclerosis, attention-deficit hyperactivity disorder, bipoloar disorder, brain damage, cancer, cardiovascular disease, cholestatic pruritis, depression, chronic obstructive pulmonary disease (COPD), cocaine abuse, cough, dermatitis, depression, drug-seeking behavior, gastrointestinal disorders, facial erythema associated with rosacea, glaucoma, hepatic diseases, hyperactive bladder, hypersensitivity disorders, hypertension, impulsivity, inflammation, mental disorders and conditions, metabolic disorders, migraines, nasal and sinus congestion, nausea, neuropathic pain with and symptoms of multiple sclerosis, neurological and neuropsychiatric disorders, obesity, obsessive-compulsive disorders, opioid-induced respiratory depression, osteoarthritis, pain, Parkinson disease, pathological gambling, peptic ulcers, schizophrenia, sleep disorders, spinal cord injury, tardive dyskinesia, tics and behavioral problems with Tourette's syndrome; as well as for supporting appetite, cardiovascular health, hematologic health, memory, metabolic health, mood, prolonged REM sleep, renal health, sexuality, sociability and metabolic, hematological, renal, and weight loss.
Owner:EPITRACKER INC

Composition for assisting in improving eosinophilic esophagitis and application thereof

The invention relates to the technical field of compositions, and particularly discloses a composition for assisting in improving eosinophilic esophagitis and application of the composition. The composition for assisting in improving eosinophilic esophagitis provided by the invention comprises an iron source, a zinc source and L-carnitine. By optimizing the components of the composition and specifically limiting the proportion of the iron source, the zinc source and the L-carnitine in the composition, esophageal epithelial hyperplasia can be effectively reversed, the number of bifidobacteria is increased, the number of enterobacter and esophageal tissue eosinophilic granulocytes is reduced, the level of IL-13 cell factors is reduced, and the curative effect is improved. Further, the effect of remarkably assisting in improving eosinophilic granulocytic esophagitis is achieved.
Owner:JUNLEBAO DAIRY GRP CO LTD

Method and reagent group for diagnosing canine pancreatitis and application of acyl carnitine in diagnosis of canine pancreatitis

The invention provides a method for diagnosing canine pancreatitis. First, a specimen of a canine animal is provided. Then, a concentration of a biomarker of the specimen is detected, if the concentration is higher than a predetermined value, it is determined that the canine has a high risk of pancreatitis, the biomarker being medium-chain acyl carnitine, long-chain acyl carnitine, or a combination thereof, where the medium-chain acyl group has a chain length of 6 to 12 carbon atoms, the long-chain acyl group has a chain length of 6 to 12 carbon atoms, and the long-chain acyl group has a chain length of 6 to 12 carbon atoms. And the long-chain acyl refers to the chain length of more than 12 carbon atoms. The invention further provides a reagent group for diagnosing the canine pancreatitis and application of the acyl carnitine to diagnosis of the canine pancreatitis.
Owner:AMX PHARMA INC

Use of carnitine palmitoyltransferase 1 inhibitors in the treatment of heart failure with preserved ejection fraction

The present invention relates to the use of carnitine palmitoyltransferase 1 inhibitors in the treatment of heart failure with preserved ejection fraction. The use in particular is the use of the carnitine palmitoyltransferase (CPT1) inhibitor Etomoxir for the prevention and / or treatment of heart failure with preserved ejection fraction by oral administration.
Owner:BEIJING INST OF HEART LUNG & BLOOD VESSEL DISEASES

Enzyme mutant, enzyme composition or immobilized enzyme thereof and application and method for preparing L-carnitine

The present invention relates to the field of enzyme engineering, and more particularly to enzyme mutants, enzyme compositions or their immobilized enzymes and their applications and methods for preparing L-carnitine. The present invention provides a simple L-carnitine holoenzyme preparation process, the overall process of which utilizes bulk betaine (N,N,N-trimethylglycine) and acetic acid as raw materials. L-carnitine is directly obtained by two-step continuous conversion by carboxyl reductase (CAR) and aldolase (DERA). This route can be completed in one step using a crude enzyme solution, or by utilizing a recyclable immobilized enzyme, and the reduced coenzyme II (NADPH) and adenosine triphosphate (ATP) used in the first step of the reaction can also be recycled using corresponding enzymes to further reduce production costs. Therefore, the patented L-carnitine preparation process has many advantages, such as being fully green, simple in process, inexpensive to produce, and easy to scale up.
Owner:SOUTH CHINA NORMAL UNIV

A direct qPCR amplification reagent, amplification kit and application for whole blood samples

This invention discloses direct amplification qPCR reagents, kits, and applications for whole blood samples. The amplification reagents include: a composite hot-start DNA polymerase system, a buffer system, a surfactant, an anti-contamination system, and an anti-inhibition enhancer system. The composite hot-start DNA polymerase system is obtained by mixing antibody-modified hot-start Taq enzyme and antibody-modified Taq1C2 mutant Taq enzyme in a predetermined ratio. The buffer system includes Tris-HCl, MgCl2, (NH4)2SO4, and KCl. The surfactants include Tween-20 and NP-40. The anti-contamination system includes UDG enzyme and dNTPs, wherein the dNTPs are composed of dATP, dGTP, dCTP, dTTP, and dUTP. The anti-inhibition enhancer system includes D-trehalose, L-carnitine, DMSO, BSA, and SSB single-chain binding protein.
Owner:河南远止生物技术有限公司 +2

Cat triple vaccine immunologic adjuvant containing two cat interleukinins and metabolism regulating molecules, composition and application

The invention relates to the technical field of biological medicine, in particular to a cat triple vaccine immunologic adjuvant containing two cat interleukinins and a metabolism regulating molecule, a composition and application. The composition comprises cat interleukin 15, cat interleukin 23 and metabolic regulation molecules, the metabolic regulation molecules comprise beta-nicotinamide mononucleotide, beta-nicotinamide adenine dinucleotide disodium salt, N-acetylcysteine and L-carnitine, and the composition can be used for preparing a cat triple vaccine or an auxiliary preparation of the cat triple vaccine. The composition can effectively improve the protection capacity of vaccines, prolong the protection time of the vaccines and reduce adverse reactions; the vaccine can reduce or control reproduction infection of viruses in a more durable and higher level mode, the specific humoral immunity level and the memory response capacity of animals are remarkably improved, and invasion and diffusion of FPV, FCV and FHV-1 are better resisted.
Owner:SICHUAN SANYOUKANG BIOTECHNOLOGY CO LTD

Solid beverage cooperating with whole body vertical rhythm training to promote weight losing and height increasing of teenagers and preparation method of solid beverage

The invention discloses a solid beverage cooperating with whole body vertical rhythm training to promote weight losing and height increasing of teenagers and a preparation method thereof. The solid beverage is composed of whey protein, soybean protein, resistant dextrin, fructo-oligosaccharide, calcium, vitamin D, vitamin K, L-carnitine, a green tea extract, a lotus leaf extract and other components, and through scientific proportioning, the solid beverage can supplement nutrition for teenagers, regulate metabolism and promote fat consumption and bone growth. The preparation method comprises the steps of raw material weighing, mixing, sieving, spray drying, sub-packaging and the like. The solid beverage is matched with whole body vertical rhythm training, the weight losing and height increasing effects of teenagers can be remarkably improved, and the product is safe, healthy, good in taste and wide in application prospect.
Owner:张智斌

Cell culture medium supplement as well as preparation method and application thereof

The invention discloses a cell culture medium supplement as well as a preparation method and application thereof, and relates to the technical field of cell biology. The supplement comprises DL-alpha-tocopheryl acetate, linolenic acid, ethanolamine, L-carnitine hydrochloride, 3, 3 ', 5-triiodoL-sodium thyrosinate, and serum albumin. As a cell culture additive with definite chemical components and simple composition, the cell culture additive can replace a traditional culture system with unknown chemical components or too complex composition, and is used for supporting proliferation, differentiation and characterization analysis of cells. The culture medium additive is clear in chemical component, simple to prepare, stable in effect and relatively low in cost, can promote in-vitro proliferation and oxidation resistance of cells including human embryonic stem cells and mesenchymal stem cells, and has important application value in actual production.
Owner:UNIV OF MACAU

Metabolite marker for colorectal cancer diagnosis and application thereof

The invention relates to a metabolite marker for early diagnosis of colorectal cancer as well as application and a device of the metabolite marker. The marker comprises sulfate, ubiquinone-1, a deoxycholic acid glycine conjugate, demethylchlorophyllin, 3-(3, 5-diiodine-4-hydroxyphenyl) lactate, vitamin K1, O-decanoyl-L-carnitine, sedoheptulose 1, 7-diphosphoric acid, cholesterol-docosahexaenoic acid ester and acyl AMP (adenosine monophosphate). The marker combination has excellent performance in colorectal cancer detection, AUROC can reach 0.97, and noninvasive screening and early diagnosis of colorectal cancer can be accurately, quickly and simply realized.
Owner:MACAU UNIV OF SCI & TECH

Preparation for improving male erectile function and sperm quality and preparation process

The invention discloses a preparation for improving male erectile function and sperm quality. The health-care food is characterized by being prepared from the following raw materials in parts by weight: 30-50 parts of herba epimedii extract, 20-40 parts of herba cistanche extract, 15-30 parts of fructus lycii extract, 18-35 parts of semen cuscutae extract, 10-25 parts of herba cynomorii extract, 8-20 parts of maca powder, 6-18 parts of raspberry extract, 0.5-2 parts of lycopene, 1-3 parts of L-carnitine and 0.3-1 part of vitamin B family (vitamin B1, vitamin B2, vitamin B6 and vitamin B12 are mixed according to the mass ratio of 1: 1: 2: 0.5). The herba epimedii extract is selected as a main component, the content of icariin is regulated to be not lower than 60%, the high-content icariin can more effectively promote sex hormone secretion, enhance sexual desire and improve erectile function, the total content of echinacoside and verbascoside in the herba cistanche extract is not lower than 45%, and the herba epimedii extract and the herba cistanche extract have the effect of promoting sex hormone secretion, enhancing sexual desire and improving erectile function. The two components have the effects of tonifying kidney yang and benefiting essence and blood, and can enhance kidney functions.
Owner:TIANJIN ZHENBIAN BIANSE ENTERPRISE MANAGEMENT CO LTD